## AIZ: Assurant, Inc. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.5% in upper entry zone (3.0-6.0%), top quartile (89th pct) cross-sectional ranking. Short-term MRS_5 (4.2%) confirms momentum alignment. Strong momentum (+7.1% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($225.22)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. AIZ SEC Filings - Assurant 10-K, 10-Q, 8-K Forms**
- Source: Stock Titan | 20251216T100756 | Neutral | Relevance: 100%
- This page provides a comprehensive resource for Assurant (AIZ) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms. Stock Titan's AI-powered platform translates these legal documents into plain language, offering summaries of key financial data and real-time alerts on insider transactions. Recent filings discuss registered offerings, prospectus supplements for new notes to redeem existing debt, and insider stock disposals by executives.

**2. Assurant stock hits all-time high of 232.45 USD**
- Source: Investing.com India | 20251216T060727 | Bullish | Relevance: 100%
- Assurant Inc. (AIZ) stock recently reached an all-time high of $232.45, reflecting strong investor confidence and robust performance including 22 consecutive years of dividend increases. The company reported impressive Q3 2025 results, exceeding EPS and revenue forecasts, and announced a new $700 million share repurchase program and a 10% dividend hike. Analysts from Keefe, Bruyette & Woods and BMO Capital have raised their price targets, indicating a positive outlook for Assurant's continued growth and shareholder value enhancement.

**3. Assurant stock hits all-time high of 232.45 USD By Investing.com**
- Source: Investing.com Canada | 20251215T230749 | Bullish | Relevance: 100%
- Assurant Inc. (AIZ) stock reached an all-time high of $232.45, reflecting strong investor confidence and the company's robust market performance. The company also reported impressive third-quarter 2025 results, with EPS and revenue surpassing expectations, leading to a new $700 million share repurchase program and a 10% dividend increase. Analyst firms like Keefe, Bruyette & Woods and BMO Capital have raised their price targets due to growth in the Housing and Lifestyle segments.

**4. Assurant stock hits all-time high of 232.45 USD**
- Source: Investing.com | 20251215T145651 | Bullish | Relevance: 100%
- Assurant Inc. (AIZ) stock reached an all-time high of $232.45, reflecting strong investor confidence and robust performance. The company's financial health is rated "GOOD" with a P/E ratio of 14.01 and a PEG ratio of 0.79, suggesting it may be undervalued. This milestone follows 22 consecutive years of dividend increases and comes amidst impressive Q3 2025 results, a new $700 million share repurchase program, and increased price targets from analysts.

**5. How To YieldBoost Assurant To 10% Using Options**
- Source: Nasdaq | 20251215T170739 | Bullish | Relevance: 100%
- Shareholders of Assurant Inc (AIZ) can enhance their income to a 10% annualized rate by selling a June 2026 covered call at the $240 strike price, in addition to the stock's 1.5% dividend yield. This strategy, termed "YieldBoost," offers a 7.6% return if the stock is called away, provided it climbs 3.3% from current levels. The article utilizes historical volatility and dividend data to assess the viability of this options trading approach.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Keefe, Bruyette | $254 | $248 | +2% |
| 2025-11-17 | Morgan Stanley | $248 | $232 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Keefe, Bruyette | main | Outperform |
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.10M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-2.0%)
- Bank Of New York Mel: 10.0% (+23.7%)
- Blackrock Inc.: 7.9% (-0.4%)
- T. Rowe Price Invest: 7.7% (-3.5%)
- State Street Corpora: 5.4% (-3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +7.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Balance sheet: strong liquidity (11492000000.0x). Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $11.8B |
| Beta | 0.57 |
| 52W Range | $174.97 - $233.32 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 11.2 |
| Current P/E | 12.0 |
| YoY Growth | 6.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -1.6% to 5.5% (+7.1% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 89th percentile. MRS_5 at 4.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.52% (CS: 89) | Strong |
| RSI_14 | 68.1 | Neutral |
| MACD Histogram | 0.33 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 1.060x | Above |
| vs SMA200 | 1.132x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $233.26
- **Stop Loss:** $225.22 (3.4% risk)
- **Target:** $245.32 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 149
- **Position Value:** $34,755.74
- **Portfolio %:** 34.76%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-10 (Est: $5.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.28 | $5.73 | +34.0% |
| 2025Q2 | $4.45 | $5.10 | +14.5% |
| 2025Q1 | $2.78 | $3.39 | +22.1% |
| 2024Q4 | $4.13 | $4.79 | +15.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*